Differential Level of Platelet Amyloid β Precursor Protein Isoforms: An Early Marker for Alzheimer Disease

作者: Monica Di Luca , Lucia Pastorino , Angelo Bianchetti , Jorge Perez , Luigi A Vignolo

DOI: 10.1001/ARCHNEUR.55.9.1195

关键词:

摘要: Objective To determine whether a differential level of platelet amyloid β precursor protein (APP) isoforms is specifically related to Alzheimer disease (AD) and it shows correlation with the progression clinical symptoms. Design After subjects were grouped according diagnosis severity dementia, APP isoform levels in platelets compared. Setting University medical centers. Patients Thirty-two patients who fulfilled diagnostic criteria for probable AD, 25 age-matched control subjects, 16 non-AD dementia. Main Outcome Measure The evaluated by means Western blot analysis immunostaining whole platelets. Messenger RNAs transcripts also reverse transcriptase polymerase chain reaction. Results ratio between intensity 130-kd 106- 110-kd was significantly lower AD group (0.31±0.15, mean±SD) compared both controls (0.84±0.2) (0.97±0.4). Clinical Diagnostic Rating score correlated (Pearson coefficient, followed Bonferroni correction, P =.01). Reverse reaction experiments showed that all experimental groups equally expressed. Conclusions pattern altered AD. In addition, alteration positive symptoms, supporting possibility consider this peripheral parameter as marker disease. These alterations are not abnormalities messenger

参考文章(49)
E Milward, R N Martins, A I Bush, D Ames, R Moir, P Fischer, J Currie, S Fuller, B Rumble, A Weidemann, The amyloid precursor protein of Alzheimer's disease is released by human platelets. Journal of Biological Chemistry. ,vol. 265, pp. 15977- 15983 ,(1990) , 10.1016/S0021-9258(18)55493-4
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh, “Mini-mental state” Journal of Psychiatric Research. ,vol. 12, pp. 189- 198 ,(1975) , 10.1016/0022-3956(75)90026-6
A. C. Alonso, T. Zaidi, I. Grundke-Iqbal, K. Iqbal, Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 5562- 5566 ,(1994) , 10.1073/PNAS.91.12.5562
G. Zubenko, M Wusylko, B. Cohen, F Boller, I Teply, Family study of platelet membrane fluidity in Alzheimer's disease Science. ,vol. 238, pp. 539- 542 ,(1987) , 10.1126/SCIENCE.3659926
J. D. Buxbaum, S. E. Gandy, P. Cicchetti, M. E. Ehrlich, A. J. Czernik, R. P. Fracasso, T. V. Ramabhadran, A. J. Unterbeck, P. Greengard, Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 6003- 6006 ,(1990) , 10.1073/PNAS.87.15.6003
R. Motter, C. Vigo-Pelfrey, D. Kholodenko, R. Barbour, K. Johnson-Wood, D. Galasko, L. Chang, B. Miller, C. Clark, R. Green, D. Olson, P. Southwick, R. Wolfert, B. Munroe, I. Lieberburg, P. Seubert, D. Schenk, Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease Annals of Neurology. ,vol. 38, pp. 643- 648 ,(1995) , 10.1002/ANA.410380413
J.E. Gardella, J. Ghiso, G.A. Gorgone, D. Marratta, A.P. Kaplan, B. Frangione, P.D. Gorevic, Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochemical and Biophysical Research Communications. ,vol. 173, pp. 1292- 1298 ,(1990) , 10.1016/S0006-291X(05)80927-1
Joseph R. Ghilardi, Mark Catton, Evelyn R. Stimson, Scott Rogers, Lary C. Walker, John E. Maggio, Patrick W. Mantyh, Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport. ,vol. 7, pp. 2607- 2611 ,(1996) , 10.1097/00001756-199611040-00040
Tom Thomas, George Thomas, Chris McLendon, Truitt Sutton, Michael Mullan, β-Amyloid-mediated vasoactivity and vascular endothelial damage Nature. ,vol. 380, pp. 168- 171 ,(1996) , 10.1038/380168A0